Scientists in China on Tuesday announced that they have cloned the first healthy rhesus monkey, a two-year-old named Retro, by tweaking the process that created Dolly the sheep.
Primates have proved particularly difficult to clone, and the scientists overcame years of failure by replacing the cloned cells that would become the placenta with those from a normal embryo.
They hope their new technique will lead to the creation of identical rhesus monkeys that can be experimented on for medical research.
However, outside researchers warned that the success rate for the new method was still very low, as well as raising the usual ethical questions around cloning.
Since the historic cloning of Dolly the sheep using a technique called somatic cell nuclear transfer (SCNT) in 1996, more than 20 different animals have been created using the process, including dogs, cats, pigs and cattle.
However it was not until two decades later that scientists managed to clone the first primates using SCNT.
A pair of identical crab-eating macaques named Hua Hua and Zhong Zhong were created using SCNT in 2018 by researchers at the Chinese Academy of Sciences Institute of Neuroscience in Shanghai.
But that breakthrough, led by the institute's Qiang Sun, only resulted in live births in fewer than two percent of attempts.
Qiang was also a senior author of the new research published in the journal Nature Communications.
He told AFP that the team had extensively researched why previous efforts to clone the rhesus monkey (Macaca mulatta) had failed.
In an earlier attempt, one monkey -- out of 35 implanted fetuses -- was born alive, but it died in less than a day.
Qiang said that one of the "major problems" was that the placentas of cloned embryos were showing abnormalities compared to those from in vitro fertilization.
So the researchers replaced the cells that later become the placenta, which are called the trophoblast, with those from a healthy, non-cloned embryo.
The trophoblast cells provide nutrients to a growing embryo, and turn into the placenta that supplies oxygen and other life-supporting assistance to the fetus.
The technique "greatly improved the success rate of cloning by SCNT" and led to the birth of Retro, Qiang said.
"Extremely difficult to succeed"
However Lluis Montoliu, a scientist at the Spanish National Centre for Biotechnology who was not involved in the research, pointed out that just one out of 113 initial embryos survived, meaning a success rate of less than one percent.
"It is extremely difficult to succeed with these experiments, with such low efficiencies," Montoliu said in a statement to the U.K. Science Media Centre in London.
If human beings were to ever be cloned -- the great ethical fear of this field of research -- then other primate species would have to be cloned first, he said.
But so far, the poor efficiency of these efforts has "confirmed the obvious: not only was human cloning unnecessary and debatable, but if attempted, it would be extraordinarily difficult -- and ethically unjustifiable," Montoliu said.
Qiang emphasized that cloning a human being was "unacceptable" in any circumstance.
For the SCNT procedure, scientists remove the nucleus from a healthy egg, then replace it with another nucleus from another type of body cell.
The embryo therefore grows into the same creature that donated the replacement nucleus.
A female rhesus monkey named Tetra was cloned in 1999 using a different technique called embryo splitting.
But this simpler technique can only produce four clones at once.
Scientists have focused on SCNT in part because it can create far more clones, with the goal of creating identical monkeys to study a range of diseases as well as test drugs.
"We're seeing the beginning of the use of these cloned monkeys now. We want to use as few animals as possible to show drug efficacy, without the interference of genetic background," said Mu-ming Poo, director of the Institute of Neuroscience in the Chinese Academy of Sciences in Shanghai,
https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LmNic25ld3MuY29tL25ld3MvZmlyc3Qtcmhlc3VzLW1vbmtleS1jbG9uZWQtcmV0cm8tbmV3LW1ldGhvZC1zY250L9IBUmh0dHBzOi8vd3d3LmNic25ld3MuY29tL2FtcC9uZXdzL2ZpcnN0LXJoZXN1cy1tb25rZXktY2xvbmVkLXJldHJvLW5ldy1tZXRob2Qtc2NudC8?oc=5
2024-01-17 11:59:00Z
CBMiTmh0dHBzOi8vd3d3LmNic25ld3MuY29tL25ld3MvZmlyc3Qtcmhlc3VzLW1vbmtleS1jbG9uZWQtcmV0cm8tbmV3LW1ldGhvZC1zY250L9IBUmh0dHBzOi8vd3d3LmNic25ld3MuY29tL2FtcC9uZXdzL2ZpcnN0LXJoZXN1cy1tb25rZXktY2xvbmVkLXJldHJvLW5ldy1tZXRob2Qtc2NudC8
Tidak ada komentar:
Posting Komentar